Related Experiment Video

Updated: May 12, 2026

A Preterm Rat Model for Pain Studies
01:37

A Preterm Rat Model for Pain Studies

Published on: February 9, 2024

The ripple effect: systems-level interventions to ameliorate pediatric pain

Jessica W Guite1, Deirdre E Logan, Elizabeth A Ely

  • 1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA ; The Children's Hospital of Philadelphia, Philadelphia, PA, USA ; Division of Pain & Palliative Medicine, Connecticut Children's Medical Center, 282 Washington Street, Hartford, CT 06106, USA.

Pain Management
|April 2, 2013
PubMed

Insights

Pediatric chronic pain management requires addressing healthcare system issues beyond the individual patient. Understanding the impact of families, schools, and healthcare settings improves treatment effectiveness for children with pain.

Area of Science:

  • Pediatric healthcare systems
  • Chronic pain management
  • Interdisciplinary care

Background:

  • Pediatric chronic pain is a significant health issue.
  • Current treatment often focuses solely on the patient, neglecting broader systemic factors.
  • Healthcare providers may lack strategies to address environmental influences on pediatric pain.

Purpose of the Study:

  • To review the systemic factors influencing pediatric chronic pain treatment.
  • To highlight the 'ripple effects' of healthcare systems on pain management.
  • To enhance healthcare providers' understanding of surrounding systems.

Main Methods:

  • Review of systems-level healthcare issues impacting pediatric pain.
  • Case example illustrating systemic challenges.
  • Analysis across outpatient pain clinics, schools, and inpatient settings.

Main Results:

  • Healthcare systems significantly impact pediatric chronic pain treatment outcomes.
  • Families, schools, and healthcare institutions are key systems to consider.
  • Interventions must extend beyond the individual patient to be effective.

Conclusions:

  • Effective pediatric chronic pain management necessitates a systems-level approach.
  • Healthcare providers need enhanced knowledge of systemic interventions.
  • Addressing families, schools, and healthcare settings improves treatment efficacy for children with pain.

More Related Videos

Electrophysiological Measurements and Analysis of Nociception in Human Infants09:18

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...